Activation of mesangial cell MAPK in responseto homocysteine  by Ingram, Alistair J. et al.
Kidney International, Vol. 66 (2004), pp. 733–745
Activation of mesangial cell MAPK in response
to homocysteine
ALISTAIR J. INGRAM, JOAN C. KREPINSKY, LEIGHTON JAMES, RICHARD C. AUSTIN,
DAMU TANG, ANNE MARIE SALAPATEK, KERRI THAI, and JAMES W. SCHOLEY
Department of Medicine, McMaster University, Hamilton, Ontario; Department of Medicine, University of Texas Southwestern
Medical Center, Dallas, Texas; and Department of Medicine, University of Toronto, Toronto, Ontario
Activation of mesangial cell MAPK in response to homocys-
teine.
Background. Alteration in mesangial cell function is central
to the progression of glomerular disease in numerous models of
chronic renal failure (CRF). Animal models of chronic glomeru-
lar disease are characterized by mesangial cell proliferation and
elaboration of extracellular matrix protein (ECM), resulting
in glomerulosclerosis. Elevated plasma levels of homocysteine
(Hcy) are seen in both animal models and humans with CRF,
and have been proposed to contribute to the high prevalence of
vascular disease in this group. Some of the pathogenetic effects
of Hcy are thought to be mediated via the induction of endo-
plasmic reticulum stress. Thus, Hcy effects on mesangial cells
could contribute to the progression of CRF. Previous work has
shown Hcy- mediated induction of Erk mitogen-activated pro-
tein kinase (MAPK) in vascular smooth muscle cells (VSMCs).
Erk induces increases in activator protein-1 (AP-1) transcrip-
tion factor activity which may augment mesangial cell prolifer-
ation and ECM protein production. Consequently, we studied
the effect of Hcy on mesangial cell Erk signaling.
Methods. Mesangial cells were exposed to Hcy after 24 hours
of serum starvation and Erk activity assessed. Nuclear translo-
cation of phospho-Erk was visualized by confocal microscopy.
AP-1 nuclear protein binding was measured in response to Hcy
by mobility shift assay. Hcy-induced mesangial cell calcium flux
was measured in Fura-2 loaded cells. Mesangial cell DNA syn-
thesis in response to Hcy was assessed by [3H]-thymidine incor-
poration and proliferation by Western blotting for proliferating
cell nuclear antigen (PCNA). Expression of endoplasmic retic-
ulum stress response genes were determined by Northern and
Western analysis.
Results. Hcy led to an increase in Erk activity that was maxi-
mal at 50 lmol/L and 20 minutes of treatment. Subsequent ex-
periments used this concentration and time point. Erk activity in
response to Hcy was insensitive to n-acetylcysteine and catalase,
indicating oxidative stress did not play a role. However, Hcy
50 lmol/L induced a brief increase in intracellular mesangial cell
calcium within 5 minutes, and the calcium ionophores A23187
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and ionomycin increased Erk activity while chelation of intra-
cellular calcium with BAPTA-AM abrogated the Erk response
to Hcy. Confocal microscopy of activated Erk nuclear transloca-
tion mirrored these results as did mesangial cell nuclear protein
binding to AP-1 consensus sequences. Hcy- induced increases
in thymidine incorporation and PCNA expression at 24 hours
were Erk dependent. The expression of endoplasmic reticulum
stress response genes was significantly elevated by Hcy in an
Erk-dependent manner.
Conclusion. Hcy increases Erk activity in mesangial cells via a
calcium-dependent mechanism, resulting in increased AP-1 nu-
clear protein binding, cell DNA synthesis and proliferation and
induction of endoplasmic reticulum stress. These observations
suggest potential mechanisms by which Hcy may contribute to
progressive glomerular injury.
The mesangial cell provides architectural support for
glomerular capillary loops [1]. Proliferation of mesan-
gial cells and elaboration of extracellular matrix protein
(ECM) are important factors in the glomerulosclerosis
that occurs in several models of chronic renal failure
(CRF) [2–5]. Both physical and chemical factors play
roles in stimulating mesangial cell proliferation and ECM
production. Intraglomerular hypertension increases the
magnitude of cyclic stretch to which mesangial cells are
exposed, and has been demonstrated to precede the ac-
cumulation of ECM protein in CRF animal models [3–5],
and interventions that decrease intraglomerular pres-
sure attenuate sclerotic injury [6, 7]. Cytokines such as
angiotensin II (Ang II) [8] and transforming growth
factor-beta (TGF-b) [9] also play critical roles in the pro-
motion of injury in these models, and transfection of ei-
ther TGF-b [10] or infusion of Ang II [11] into intact
animal glomeruli results in sclerosis. Sclerotic glomeruli
are also characterized by resident cell loss, and evidence
is accumulating that apoptosis is an important mechanism
in progressive glomerular injury [12–14].
Homocysteine (Hcy) is a thiol-containing amino acid
formed as an intermediate metabolite in the conver-
sion of methionine to cysteine [15]. Elevated plasma
levels of Hcy have been identified as an important and
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independent risk factor for myocardial infarction [16]
and atherosclerosis in humans [17, 18]. It is now well
established that patients with CRF have the highest
nongenetically determined plasma Hcy levels seen in
clinical practice [19, 20], and this has been reported to
be an independent risk factor for adverse cardiovascular
outcomes in these patients [21, 22]. In Dahl salt-sensitive
rats, a high methionine diet exacerbated proteinuria and
glomerulosclerosis, an effect attributed to the hyperho-
mocysteinemia that results from methionine loading [23].
Whether elevated ambient levels of Hcy contribute to
progression of glomerular disease in humans, however, is
unknown.
Recent in vitro data support this possibility, however.
Hcy treatment for 48 hours increases mesangial cell pro-
liferation and collagen I in culture [24]. This is consis-
tent with the effects of Hcy on the systemic vasculature,
which has been more extensively studied. Aortic vascular
smooth muscle cells (VSMC) proliferate when exposed
to Hcy [25, 26] and increase their production of colla-
gen [27, 28]. Conversely, endothelial cells show an inhibi-
tion of DNA synthesis and proliferation when exposed to
Hcy [29]. Apoptosis has also been observed in endothelial
cells exposed to Hcy, and induction of the unfolded pro-
tein response and endoplasmic reticulum stress appear
to mediate this effect [30]. Mitogen-activated protein ki-
nase (MAPK) signaling may also be important in me-
diating these effects- Hcy activated Erk in VSMC [31],
but inhibited it in endothelial cells [32]. In monocytes,
Hcy activated Erk in a reactive oxygen species (ROS)-
dependent manner, and downstream cytokine secretion
was Erk dependent [33]. We and others have established
that Erk signaling induces mesangial cell proliferation in
response to numerous stimuli [34–39], while data also in-
dicate that Erk signaling may induce endoplasmic reticu-
lum stress in response to hypoxia or intracellular calcium
release [40, 41].
Accordingly, we studied whether Hcy might lead to ac-
tivation of Erk MAPK in mesangial cells, and the mech-
anisms thereof. Furthermore, we studied whether two
downstream events implicated in vascular injury, prolif-
eration and endoplasmic reticulum stress, were also af-
fected by Hcy in mesangial cells in an Erk-dependent
manner.
METHODS
Materials and cell culture
Sprague- Dawley rat mesangial cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 20% fetal calf serum (FCS) (Gibco BRL,
Mississauga, Ontario, Canada), streptomycin (100 lg/
mL), penicillin (100 U/mL), and 2 mmol/L glutamine at
37◦C in 95% air/5% CO2 as described previously [38, 39].
Experiments were carried out in cells from passages 5
to 10. DL-Hcy, catalase, n-acetylcysteine, and BAPTA-
AM were from Sigma Chemical Co. (St. Louis, MO,
USA). PD98059 and U0126 were from Calbiochem (San
Diego, CA, USA) and Promega (Madison, WI, USA),
respectively.
MAPK (Erk) activity
Protein isolation and Western blotting. Initially, the
time course and concentration dependence of Erk
activation in response to Hcy were studied, and sub-
sequent experiments performed with 50 lM Hcy at
20 minutes. Cultures were serum-starved for 20 minutes
prior to the addition of Hcy and/or inhibitors. After incu-
bation with Hcy and/or inhibitors, media was removed
and the cells washed once with ice-cold phosphate-
buffered saline (PBS). PBS was then removed and cells
harvested under nondenaturing conditions on ice by in-
cubation for 5 minutes with 0.5 mL 1× ice-cold cell ly-
sis buffer [20 mmol/L Tris (pH 7.4), 150 mmol/L NaCl,
1 mmol/L ethylenediaminetetraacetic acid (EDTA),
1 mmol/L egtazic acid (EGTA), 1% Triton, 2.5 mmol/L
sodium pyrophosphate, 1 mmol/L b- glycerophosphate,
1 mmol/L sodium orthovanadate, and 1 lg/mL leupeptin
and 1 mmol/L phenylmethylsulfonyl fluoride (PMSF)].
Cells were then scraped into microcentrifuge tubes on
ice and sonicated four times for 5 seconds each. Af-
ter microcentrifugation at 14,000 rpm for 10 minutes
at 4◦C, the supernatant was transferred to a fresh mi-
crocentrifuge tube. Protein concentration was measured
with the Bio-Rad Assay Kit (Bio-Rad, Hercules, CA,
USA). Subsequently, 40 lg of sample was separated on a
12% sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE), and electroblotted to a nitro-
cellulose membrane (Protran, Schleicher and Schuell,
Keene, NH, USA). Membranes were incubated for
3 hours at room temperature with 25 mL of block-
ing buffer [1× Tris-buffered saline (TBS), 0.1% Tween-
20 (TTBS) with 5% wt/vol nonfat dry milk], and then
overnight at 4◦C with Erk MAPK (thr 202/tyr 204) poly-
clonal antibody (1:1000) (New England Biolabs, Beverly,
MA, USA) in 10 mL of antibody dilution buffer [1×
TBS, 0.05% Tween-20 with 5% bovine serum albumin
(BSA)] with gentle rocking overnight at 4◦C. Membranes
were then washed three times with TTBS and then in-
cubated with horseradish peroxidase (HRP)-conjugated
antirabbit secondary antibody (1:2000) in 10 mL of block-
ing buffer for 45 minutes at room temperature. After
three further TBS washes, the membrane was incubated
with LumiGlo reagent (KPL Inc., Gaithersburg, MD,
USA) and then exposed to x-ray film (X-OMAT, Kodak,
Rochester, NY, USA).
Activity assays. After protein isolation from total cell
lysate as above, 200 lg total protein was then incu-
bated with Erk MAPK (thr 202/tyr 204) monoclonal
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antibody (1:200) (New England Biolabs) with gentle
rocking overnight at 4◦C. Protein sepharose A beads
(20 lL of 50% beads) were then added and the gentle
rocking continued for 3 further hours. Lysate was then
microcentrifuged for 30 seconds at 14,000 rpm to recover
the beads, and the pellet washed twice with 0.5 mL of
1× lysis buffer. For the kinase assay, after immunopre-
cipitation, pellets were washed twice with 0.5 mL kinase
buffer [25 mmol/L Tris, 5 mmol/L b-glycerophosphate, 2
mmol/L dithiothreitol (DTT), 0.1 mmol/L sodium ortho-
vanadate, and 10 mmol/L MgCl2]. Erk MAPK activity
was then performed by suspending the pellet in 50 lL
of 1× kinase buffer, with 200 lmol/L adenosine triphos-
phate (ATP) and 2 lg Elk-1 fusion protein as substrate.
After incubation for 30 minutes at 30◦C, the reaction
was terminated with 25 lmol/L 3× SDS sample buffer
[187.5 mmol/L Tris-HCl (pH 6.8), 6% wt/vol SDS, 30%
glycerol, 150 mmol/L DTT, and 0.3% wt/vol bromphenol
blue], boiled for 5 minutes, vortexed, and then micro-
centrifuged for 2 minutes. Twenty microliters of sample
was then run on an SDS-PAGE gel. After blotting to ni-
trocellulose, membranes were incubated for 3 hours at
room temperature with 25 mL of blocking buffer (1×
TBS, 0.1% Tween-20 with 5% wt/vol nonfat dry milk),
and then overnight at 4◦C with phospho-specific anti-Elk-
1 (ser 383) antibody 1:1000 in 10 mL of antibody dilu-
tion buffer (1× TBS, 0.05% Tween-20 with 5% BSA).
Gels were washed 3 times with TTBS and then incu-
bated with HRP-conjugated anti-rabbit secondary anti-
body (1:2000) for 1 hour at room temperature. After three
further TBS washes, the membrane was incubated with
LumiGlo reagent (KPL Inc.) and then exposed to X-ray
film (X-OMAT).
Assessment of intracellular oxidative stress. The
H2O2-sensitive fluorescent probe 5-(and-6)chloro-
methyl-2′,7′-dichlorodihydrofluorescein diacetate acetyl
ester (CM-H2DCFDA) (Molecular Probes, Eugene, OR,
USA) was used to assess the production of intracellular
H2O2. Intracellular esterases convert this compound
to 2′,7′-dichlorofluorescein which is then oxidized by
H2O2 to the fluorescent 2′,7′-dichlorofluorescein. Sub-
confluent mesangial cells were made quiescent by serum
deprivation in 0.5% serum for 24 hours. Cells were then
incubated with 10 lmol/L CM-H2DCFDA for 30 min
at 37◦C in PBS. This was replaced by fresh media after
washing, and mesangial cells were treated with 3000 U/
mL catalase or 1 mmol/L n-acetylcysteine for 10 minutes
prior to incubation with 50 lmol/L Hcy for 20 minutes.
Mesangial cells were then fixed for 10 minutes in 3.7%
formaldehyde, mounted in DAPI-containing mounting
medium (Vectashield, Burlingame, CA, USA) and im-
aged using a fluorescent microscope (Zeiss, Thornwood,
NY, USA) at an excitation wavelength of 488 nm and an
emission wavelength of 510 to 550 nm.
Phospho-Erk nuclear translocation. Mesangial cells
(passages 5 to 10) were grown on glass slips for these
experiments exactly as above. After incubation with
Hcy with or without inhibitors, cells were washed three
times with PBS and fixed with 3.7% formaldehyde
(300 lL/well) for 10 minutes at room temperature. Cells
were washed three times with PBS and then perme-
abilized in 0.1% Triton for 2 minutes on ice, washed
again with PBS and incubated with antiphospho-Erk
(thr202/tyr204) (New England Biolabs) 1:50 in PBS for
30 minutes at room temperature. Following three further
PBS washes, cells were incubated with an Alexa 488 goat
antirabbit green IgG (H + L) fluorescent-conjugated an-
tibody (Molecular Probes) 1:50 in PBS (the secondary
antibody was recovered by centrifugation at 12000 rpm
for 10 minutes prior to application) for 30 minutes at
room temperature in the dark. After washing, a drop of
antifade mount media mixture was added and mesangial
cells covered with a glass slip. Slides were stored at 4◦C
in the dark until confocal microscopy laser scanning was
performed using a Bio-Rad MRC-600 confocal micro-
scope (Bio-Rad, Mississauga, Ontario, Canada) within 7
days.
Nuclear protein binding to activated protein-1 (AP-1)
consensus sequences. After washing in cold PBS, nuclear
extracts of mesangial cells were prepared by lysis in hypo-
tonic buffer (20 mmol/L Hepes, pH 7.9, 1 mmol/L EDTA,
1 mmol/L EGTA, 20 mmol/L NaF, 1 mmol/L Na3VO4,
1 mmol/L Na4P2O7, 1 mmol/L DTT, 0.5 mmol/L PMSF,
1 lg/mL aprotinin, 1 lg/mL leupeptin, 1 lg/mL pep-
statin A, and 0.6% Nonidet P-40), homogenized and sed-
imented at 16,000g for 20 minutes at 4◦C. Pelleted nuclei
were resuspended in hypotonic buffer with 0.42 mol/L of
NaCl2 and 20% glycerol and rotated for 30 minutes at
4◦C. After centrifugation for 20 minutes at 16,000g, the
supernatant was collected and protein concentration was
measured with the Bio-Rad Assay Kit.
AP-1 consensus oligonucleotides were prepared by in-
cubating 2 lL consensus oligonucleotide (1.75 pmol/uL),
1 lL T4 polynucleotide kinase 10× buffer, 1 lL [c-32P]-
ATP (3000 Ci/mL) (DuPont, Boston, MA, USA) and 5 lL
nuclease-free water for 10 minutes at 37◦C. The reaction
was stopped by adding 1 lL of 0.5 mol/L EDTA. Unla-
beled [32P]-ATP was removed from the oligonucleotide
mixture with D-25 Sephadex columns.
The supernatants were used as nuclear proteins for the
binding assay. Three micrograms of nuclear proteins were
incubated with 2 lg of poly(dI-dC).poly(dI.dC) (Phar-
macia, Uppsala, Sweden) in binding buffer (20 mmol/L
Hepes, pH 7.9, 1.8 mmol/L MgCl2, 2 mmol/L DTT, 0.5
EDTA, and 0.5 mg/mL BSA), incubated for 30 minutes
at room temperature and then reacted with radiolabeled
consensus oligonucleotides at room temperature for
20 minutes (50,000 cpm to 100,000 cpm). Reaction mix-
tures were electrophoresed in a 6% polyacrylamide gel
and autoradiographed. Competition experiments were
performed with excess unlabeled consensus oligonu-
cleotides in 100× excess.
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Calcium influx. Mesangial cells grown on glass cov-
erslips were preloaded for 30 minutes in the dark with
the calcium sensitive fluorescent dye Fura-2/AM (5 lM)
in DMEM with 1 mg/mL BSA. After washing, mesan-
gial cells were mounted in a chamber with 1.5 mL Hepes-
buffered NaCl solution containing 1.5 mmol/L CaCl2 and
1.0 mmol/L MgCl2. The chamber was mounted in a flu-
orescence microscope (Zeiss) and 50 lmol/L Hcy was
added. Fluorescence measurements were performed at
emission wavelength 500 nm and excitation wavelengths
of 340 and 380 nm, representing fluorescence of calcium-
bound and unbound dye, respectively. Cytosolic free cal-
cium was then calculated from the ratio (R) of the two
wavelengths according to the standard formula [42], with
Rmax and Rmin calculated according to standard method-
ology [42].
[3H]-thymidine Incorporation. Incorporation of [3H]-
thymidine was performed as we have previously pub-
lished [38]. Briefly, subconfluent mesangial cells were
made quiescent by serum deprivation in 0.5% serum
for 24 hours. Mesangial cells were then incubated with
50 lmol/L Hcy with or without the extracellular signal-
related protein kinase (ERK) (MEK-1) inhibitor U0126
or the calcium chelator BAPTA-AM (both used at
10 lmol/L) for 24 hours. [3H]-thymidine was added for
the last 4 hours of this period. Mesangial cells were then
washed three times with ice-cold PBS, incubated in ice-
cold 5% trichloroacetic acid for 25 minutes and dissolved
in 500 lL 0.2 mol/LNaOH. [3H]-thymidine incorporation
was counted on a Beckman LS7500 Scintillation counter.
Protein concentrations were determined in each well as
above, and [3H]-thymidine incorporation expressed as
counts per minute per microgram protein.
Western Blotting for proliferating cell nuclear antigen
(PCNA) and endoplasmic reticulum stress proteins. Af-
ter serum starvation, mesangial cells were incubated with
50 lmol/L Hcy for 24 hours. Subsequently, protein was
isolated as above, and 40 lg of sample was separated
on a 12% SDS-PAGE gel, and electroblotted to a ni-
trocellulose membrane. Membranes were incubated for
1 hour at room temperature with 25 mL of blocking
buffer (1× TBS, 0.1% Tween-20 with 5% wt/vol non-
fat dry milk) and then for 1 hour at room temperature
with either monoclonal anti-PCNA antibody (1:1000 in
antibody dilution buffer) (Novocastra Labs., Newcastle,
UK), anti-GRP 78/GRP 94 (1:3000) (StressGen, Victo-
ria, British Columbia, Canada) as we have published
[15], polyclonal antiprotein disulfide isomerase (PDI)
(1:1000) (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) or polyclonal anti-GADD153 (1:1000) (Santa Cruz
Biotechnology). Following three TTBS washes, a 1-hour
incubation with the appropriate HRP-conjugated sec-
ondary antibody 1:2000 was performed. After three fur-
ther TBS washes, the membrane was incubated with Lu-
miGlo reagent (KPL Inc.) and then exposed to x-ray film
(X-OMAT; Kodak).
Northern analysis
Total RNA was isolated from Hcy-treated mesangial
cells as indicated using the RNeasy total RNA kit (Qia-
gen Inc., Mississauga, Ontario, Canada) and resuspended
in diethyl pyrocarbonate–treated water. Quantification
and purity of the RNA was assessed by A260/A280 ab-
sorption, and RNA samples with ratios above 1.6 were
stored at −70◦C for further analysis. Total RNA (10 lg/
lane) was size fractionated on 2.2 mol/L formalde-
hyde/1.2% agarose gels, transferred to Zeta-Probe GT
nylon membranes (Bio-Rad Laboratories), and hy-
bridized using radiolabeled cDNA probes as we have
described [15, 43]. Signal intensities were quantified by
densitometric scanning of the autoradiograms using the
ImageMaster VDS and Analysis Software (Amersham
Pharmacia Biotech, Baie d’Urfe´, PQ, Canada). To correct
for differences in gel loading, integrated optical densities
were normalized to human glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The cDNA probe encoding
GRP78/BiP has been described previously [15, 43].
Statistical analysis
Analyses were performed with analysis of variance
(ANOVA), using Tukey’s HSD for post hoc analysis to
determine differences between individual groups when
ANOVA was siginificant. A two-tailed P < 0.05 was con-
sidered significant. Analyses were performed with SPSS
for Windows, version 11.0.
RESULTS
Erk protein and activity
Initially, we studied Erk activation in mesangial cells
exposed to Hcy. The in vitro activity of Erk was mea-
sured in immunoprecipitates from cell lysates after in-
cubation with an Elk-1 fusion protein. Phosphorylation
of the substrate, Elk-1, was then detected by Western
blot analysis with a specific antibody to phosphorylated
Elk-1. Incubation of mesangial cells with Hcy for 1 hour
at concentrations from 5 lmol/L to 5 mmol/L led to an
increase in Erk activity that was maximal at 50 lmol/L
(Fig. 1A). Accordingly, we subsequently used a concen-
tration of 50 lmol/L, as this plasma level is commonly
seen in patients with CRF. No change in the amount of
Erk protein was seen under any condition. Some cyto-
toxicity was observed only at 5 mmol/L, with about 5%
of cells floating after 1-hour incubation at this concen-
tration (data not shown). Time course studies with Hcy
50 lmol/L revealed maximal Erk activity after 20 min-
utes, with decay thereafter (Fig. 1B). Consequently, sub-
sequent experiments were performed at this time point.
No activation of Erk was seen with cysteine at doses up
to 1 mmol/L (data not shown).
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Fig. 1. Induction of Erk activity in mesangial cells by homocysteine
(Hcy) is concentration- and time-dependent. The in vitro activity of
Erk was measured in immunoprecipitates from mesangial cell lysates
by detection of phosphorylation of an Elk-1 fusion protein by Western
blotting. (A) Incubation of mesangial cells with Hcy for 1 hour at con-
centrations from 5 lmol/L to 5 mmol/L led to an increase in Erk activity
that was maximal at 50 lmol/L (middle panel). No change in the amount
of Erk protein was seen under any condition (top panel). Changes in
activity are presented graphically with error bars (bottom panel) (N =
4). Erk activity at 50 lmol/L was significantly different from baseline
and other concentrations (P < 0.01). (B) Incubation of mesangial cells
with Hcy at 50 lmol/L for the times indicated led to an increase that
was maximal at 20 minutes (middle panel). No change in the amount
of Erk protein was seen under any condition (top panel). Changes in
activity are presented graphically with error bars (bottom panel) (N
= 4). Erk activity at 20 minutes only was significantly different from
baseline and other time points (P < 0.05). MAPK is mitogen-activated
protein kinase.
Mediators of Erk activity in response to Hcy
Next, we wished to explore mechanisms by which Hcy
might activate Erk signaling. It is well-established that
thiols, including Hcy, can generate ROS as a consequence
of their rapid auto-oxidation [44], and recent data have
indicated that Hcy enhances tissue-inhibitor of metallo-
proteinase (TIMP-1) expression in mesangial cells via the
induction of oxidative stress [24]. We have also shown
that Hcy impairs the generation of antioxidant enzymes
in endothelial cells [43]. Consequently, we sought to de-
termine whether oxidative stress and the generation of
ROS played a role in activation of Erk by preincubating
mesangial cells with n-acetylcysteine (1 mmol/L) (Sigma)
or catalase (3000 U/mL) (Sigma) for 10 minutes prior to
the addition of Hcy. Figure 2A shows that neither antiox-
idant affected the Erk activity observed in response to
Hcy. In order to ensure that n-acetylcysteine and catalase
were providing effective relief of oxidative stress in Hcy-
treated mesangial cells, we employed the H2O2-sensitive
fluorescent probe CM-H2DCFDA. Figure 2B shows that
50 lmol/L Hcy for 20 minutes increased CM-H2DCFDA
fluorescence in mesangial cells when compared with base-
line. Preincubation with n-acetylcysteine (1 mmol/L) or
catalase (3000 U/mL) effectively prevented the Hcy-
induced increase in CM-H2DCFDA fluorescence.
Hcy has also been shown to induce calcium transients
in VSMC [45], and an increase in intracellular calcium has
been observed to activate Erk in several cell lines [46].
There is indirect evidence that Hcy activation of Erk in
VSMC is calcium-sensitive [31]. We therefore wished to
determine whether calcium played a role in the mesangial
cell Erk response to Hcy. As demonstrated in Figure 2C,
BAPTA-AM (10 lM) (Sigma), an intracellular calcium
chelator, completely abrogated Hcy-induced Erk activ-
ity in mesangial cells when added 10 minutes prior to
Hcy. Supporting this observation, exposure of mesangial
cells to the calcium ionophore A23187 (1 lg/mL) (Alexis,
San Diego, CA, USA) (Fig. 2C) or ionomycin (data not
shown) also led to Erk activation.
Since calcium chelation was able to prevent Hcy-
induced activation in mesangial cells, we sought to
determine whether Hcy induced a calcium transient
in mesangial cells, as has been observed by others in
VSMC [45]. Figure 3 shows a representative view of the
consistently-observed rapid increase in intracellular cal-
cium, with a peak of 225 nmol/L, that was sustained above
baseline (100 nmol/L) for 6 minutes (N = 11).
Translocation of phospho-Erk in response to Hcy
Figure 4 shows that calcium is important for translo-
cation of phospho-Erk to the nucleus. Figure 4A shows
background cytoplasmic and nuclear staining in nor-
mal mesangial cells, and Figure 4B shows the prompt
nuclear translocation of phospho-Erk after 20 minutes
of 50 lmol/L Hcy. However, the addition of BAPTA-
AM (10 lmol/L) (Fig. 4C) virtually abrogated the
phospho-Erk translocation observed in response to Hcy,
recapitulating the results obtained with activity as-
says. Neither n-acetylcysteine (1 mmol/L) nor catalase
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Fig. 2. Mediators of homocysteine Hcy-induced Erk activation in
mesangial cells. The in vitro activity of Erk was measured in immuno-
precipitates from mesangial cell lysates by detection of phosphoryla-
tion of an Elk-1 fusion protein by Western blotting. (A) Incubation of
mesangial cells with 50 lmol/L Hcy for 20 minutes led to an increase in
Erk activity that was unaffected by pre-incubation with n-acetylcysteine
(1 mmol/L) nor catalase (Cat) (3000 U/mL) for 10 minutes prior to the
addition of Hcy. The MEK inhibitor PD98059 effectively abrogated
Erk activity, as anticipated (middle panel). No change in the amount
of Erk protein was seen under any condition (top panel). Changes
in activity are presented graphically with error bars (bottom panel)
(N = 4). Erk activity in the presence of Hcy was significantly greater
than baseline or Hcy with PD98059 (P < 0.01), but not different from
Hcy with n-acetylcysteine or catalase. (B, located on the next page)
The H2O2-sensitive fluorescent probe (CM-H2DCFDA) (Molecular
Probes, Eugene, OR, USA) was used to assess the production of intra-
cellular H2O2 and the ability of catalase and n-acetylcysteine to relieve
oxidative stress in this system. Subconfluent quiescent mesangial cells
were treated with 3000 U/mL catalase or 1 mmol/L n-acetylcysteine
for 10 minutes prior to incubation with 50 lmol/L Hcy for 20 minutes,
then fixed in formaldehyde, mounted in DAPI-containing mounting
medium, and imaged
(3000 U/mL) had any effect on phospho-Erk transloca-
tion (data not shown).
AP-1 nuclear protein binding in response to Hcy
Since increased AP-1 transactivational activity is im-
portant in both mesangial cell proliferation [47–49], and
endoplasmic reticulum stress induction in response to
increased intracellular calcium or hypoxia [40, 41], we
next studied whether Hcy-induced changes seen in Erk
activity led to downstream increases of nuclear protein
binding to AP-1 consensus sequences in mesangial cells.
As shown in Figure 5, Hcy 50 lmol/L for 20 minutes re-
sulted in a marked increase in nuclear protein binding
that was primarily Erk dependent, as it was largely pre-
vented by pre-incubation with the Erk inhibitor PD98059
(10 lmol/L) (Calbiochem). The antioxidants n-acetyl-
cysteine and catalase were without effect. However, the
increase in AP-1 nuclear protein binding observed in
response to Hcy could be abrogated by BAPTA-AM
(Fig. 6), again supporting a role of calcium in this sig-
naling pathway. It should be noted that nuclear protein
binding to AP-1 consensus sequences may not be propor-
tional to AP-1–mediated transactivation.
Mesangial cell DNA synthesis and proliferation in
response to Hcy
To ascertain whether any functional outcome impor-
tant to progressive glomerular disease might be im-
pacted through this Hcy-activated signaling pathway, we
studied mesangial cell DNA synthesis and proliferation
in response to Hcy. Incubation of mesangial cells with
50 lmol/L Hcy, a plasma concentration often seen in hu-
man subjects with CRF [20, 50], for 24 hours led to an
increase in [3H]-thymidine incorporation by mesangial
cells (Fig. 7A) and to an increase in expression of PCNA
by Western blot (Fig. 7B). Preincubation with MEK-1
inhibitors U0126 (Fig. 7A) or PD98059 (Fig. 7B), both
10 lmol/L, abrogated this, demonstrating the Erk de-
pendence of the effect. Preincubation with BAPTA-AM
using a fluorescent microscope. Panel A shows untreated cells; panel
B shows mesangial cells exposed to 50 lmol/L Hcy for 20 minutes;
panel C shows mesangial cells coincubated with Hcy and catalase (3000
U/mL); and panel D shows mesangial cells coincubated with Hcy and
n-acetylcysteine (1 mmol/L). (C) Incubation of mesangial cells with
50 lmol/L Hcy for 20 minutes led to an increase in Erk activity that
was abrogated by preincubation with BAPTA-AM (10 lmol/L) an in-
tracellular calcium chelator, when added 10 minutes prior to Hcy. The
20-minute exposure to the calcium ionophore A23187 (1 lg/mL, Alexis)
also activated Erk, although not to the same extent as Hcy (all middle
panel). No change in the amount of Erk protein was seen under any con-
dition (top panel). Changes in activity are presented graphically with
error bars (bottom panel) (N = 4). Erk activity in response to Hcy or
A23187 was signficantly greater than baseline or Hcy with BAPTA-AM
(P < 0.03).
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Fig. 2B.
also prevented [3H]-thymidine incorporation in re-
sponse to Hcy. Both MEK-1 inhibition and BAPTA-AM
markedly reduced [3H]-thymidine incorporation, attest-
ing to the importance of Erk signaling and calcium in
mesangial cell DNA synthesis in general.
Endoplasmic reticulum stress in response to Hcy
Induction of endoplasmic reticulum stress genes, such
as the molecular chaperones Grp78 and 94, GADD 153
and PDI, are critical to the maintenance of cellular via-
bility in response to many extracellular stresses, such as
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Fig. 3. Homocysteine (Hcy) induces a rise in intracellular calcium in
mesangial format. Mesangial cells grown on glass slips were loaded
with Fura-2/AM and intracellular calcium measured after exposure to
50 lmol/L Hcy. A rapid peak in intracellular calcium after addition of
50 lmol/L Hcy is observed (N = 11).
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Fig. 4. Nuclear translocation of phospho-ERK is induced by homocys-
teine (Hcy). Mesangial cells grown on glass slips were incubated with
Hcy with or without inhibitors, permeabilized, and incubated with anti
phospho-Erk for 30 minutes and subsequently with a secondary goat an-
tirabbit green fluorescent-conjugated antibody and confocal laser scan-
ning microscopy performed. (A) Background cytoplasmic and nuclear
staining in normal mesangial cells. The addition of 50 lmol/L Hcy for 20
minutes (B) led to a prompt (20 minutes) increase in staining that was
almost entirely nuclear in distribution. Preincubation with BAPTA-AM
(10 lmol/L for 10 minutes) (C) abrogated the nuclear translocation of
phospho-Erk observed with Hcy. Four separate experiments were per-
formed and representative fields shown.
treatment with calcium ionophores and oxidative stress
[51, 52]. We and others have shown that induction of en-
doplasmic reticulum stress is seen in response to Hcy in
endothelia, although studies of this effect have consis-
tently used nonphysiologic doses of Hcy (1 mmol) [15,
43, 53, 54]. Recent data indicates that endoplasmic retic-
ulum stress genes can be induced in response to increased
intracellular calcium or chronic hypoxia through an
Erk/AP-1 mechanism [51, 52]. Accordingly, we sought to
determine whether endoplasmic reticulum stress genes
were induced in mesangial cells exposed to physiologic
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Fig. 5. Erk-dependent nuclear protein binding to activator protein-1
(AP-1) consensus sequences is induced by homocysteine (Hcy). Nu-
clear proteins were reacted with radiolabeled AP-1 consensus oligonu-
cleotides for 20 minutes, electrophoresed, and autoradiographed. Lane
1 shows nuclear protein binding in normal mesangial cells. Addition
of 50 lmol/L Hcy for 20 minutes led to an increase in nuclear pro-
tein binding (lane 2) that was unaffected by preincubation with n-
acetylcysteine (1 mmol/L) or catalase (3000 U/mL) for 10 minutes prior
to the addition of Hcy (lanes 3 and 4). The Erk inhibitor PD98059
(10 lmol/L for 10 minutes prior to Hcy) largely prevented the in-
crease in nuclear protein binding (lane 5). Competition experiments
were performed with excess unlabelled consensus oligonucleotides in
100× excess (lane 6). Four separate experiments were performed and
a representative autoradiograph is shown. Densitometry revealed that
nuclear protein binding to AP-1 consensus sequences in the presence
of Hcy was significantly greater than baseline or Hcy with PD98059
(P < 0.05), but not different from Hcy with n-acetylcysteine or catalase.
elevations of Hcy, and whether this was Erk dependent.
Mesangial cell treatment with 50 lmol/L Hcy led to an
increase in Grp78 mRNA levels by Northern analysis,
an effect completely eliminated by the specific MEK in-
hibitor U0126, although U0126 alone has a lesser effect
to increase Grp78 (Fig. 8). This effect was specific to Hcy,
as cysteine had no effect (Fig. 8). Immunoblotting indi-
cated that all endoplasmic reticulum stress genes exam-
ined were induced by 50 lmol/L Hcy in mesangial cells
(Fig. 9). These data indicate that physiologic doses of
Hcy induce both proliferation and endoplasmic reticulum
stress in mesangial cells, and that both of these responses
are Erk dependent.
DISCUSSION
The mesangial cell is instrumental in the progression
of chronic glomerular disease, and both proliferation and
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Fig. 6. Homocysteine (Hcy)-induced nuclear protein binding to acti-
vator protein-1 (AP-1) consensus sequences is calcium-dependent. Nu-
clear proteins were reacted with radiolabeled AP-1 consensus oligonu-
cleotides for 20 minutes, electrophoresed, and autoradiographed. Lane
1 shows nuclear protein binding in normal mesangial cells. Addition
of 50 lmol/L Hcy for 20 minutes led to an increase in nuclear protein
binding (lane 2) that was prevented by preincubation with BAPTA-
AM (10 lmol/L) for 10 minutes prior to the addition of Hcy (lanes 3
and 4).Competition experiments were performed with excess unlabeled
consensus oligonucleotides in 100×excess (lane 5). Four separate exper-
iments were performed and a representative autoradiograph is shown.
Densitometry indicated that nuclear protein binding to AP-1 consensus
sequences in the presence of Hcy was significantly greater than baseline
or Hcy with BAPTA-AM (P < 0.02).
matrix production are observed [2, 3]. The signaling path-
ways leading to proliferation and synthesis of ECM have
been studied, and MAPK activation has been observed
in response to both physical and chemical stimuli. Pre-
vention of intraglomerular hypertension in animal mod-
els [6, 7] and human studies [55] ameliorates progressive
glomerular injury. We have demonstrated activation of
MAPKs, including Erk, in response to cyclic stretch in
mesangial cells [38], and activation of Erk in glomeruli
in vivo has recently been demonstrated in the Dahl
salt-sensitive rat [56]. The most studied chemical stim-
uli in models of progressive glomerular disease are the
cytokines such as Ang II [8] and TGF-b [57]. Ang II
signaling in VSMC results in proliferation and matrix
production, and these effects are also dependent on
Erk signaling [58, 59]. Inhibition of Erk attenuates re-
sponsiveness of VSMC to Ang II, further implicating
this signaling pathway [60]. Most important, Ang II in-
fusion results in activation of glomerular Erk in intact
rats, providing direct evidence of the existence of this sig-
naling pathway in kidney [61]. It appears that MAPKs
are also involved in TGF-b signaling, perhaps through
Erk-mediated phosphorylation of Smad1 [62].
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Fig. 7. Mesangial cell DNA synthesis and proliferation is induced by
homocysteine (Hcy). Mesangial cells were exposed to 50 lmol/L Hcy
for 24 hours. DNA synthesis was assessed by [3H]-thymidine incor-
poration (A) and proliferation by Western blotting for proliferating
cell nuclear antigen (PNCA) (B). In (A), Hcy increases mesangial cell
[3H]-thymidine incorporation at 24 hours by a factor of 1.3, a statisti-
cally significant result (P < 0.05). Preincubation with either the MEK-1
inhibitor U0126 or BAPTA-AM prevented [3H]-thymidine incorpo-
ration in response to Hcy, and both inhibitors significantly prevented
DNA synthesis when compared to either baseline or Hcy (P < 0.03). In
(B), Hcy (lane 2) markedly increased PCNA expression, which was ab-
rogated by preincubation with the Erk inhibitor PD98059 (10 lmol/L)
(lane 3). Densitometric results are shown graphically below with er-
ror bars (N = 4). The increase in PCNA expression was significantly
different in Hcy-treated cells when compared to baseline or Hcy with
PD98059 (P < 0.05).
CRF is associated with the highest levels of nongenet-
ically determined plasma Hcy seen in routine clinical
practice [19, 63]. Epidemiologic evidence links hyperho-
mocysteinemia to adverse cardiovascular outcomes in the
end-stage renal disease (ESRD) population [22, 50, 64],
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Fig. 8. Mesangial cell Grp78 induction by homocysteine (Hcy). Mesan-
gial cells were exposed to 50 lmol/L Hcy with or without 10 lmol/L
U0126 for 24 hours and RNA extracted for Northern analysis. Each
lane was loaded with 5 lg RNA and hybridized using a radiolabeled
cDNA probe to Grp78. (A) A representative autoradiograph is shown
(N = 3). (B) Densitometric results are shown graphically with error
bars (N = 4). Statistical analysis revealed that only Hcy alone signifi-
cantly increased Grp78 mRNA when compared to control (P < 0.05).
Abbreviations are: Cys, cysteine; GAPDH, glyeraldehyde-3-phosphate
dehydrogenase.
recapitulating the findings of large trials in the general
population [16, 65]. Evidently, the vascular wall is a major
target for the pathologic effects of Hcy, and consequently
most work has concentrated on the two major cell types
of arterial walls, the VSMC and vascular endothelial cells
(VEC). VSMC proliferate in the presence of Hcy, with
up-regulation of cyclin A [25, 26]. This was attributed
to the auto-oxidation of the free sulfhydryl groups on
Hcy [26]. N-acetylcysteine was demonstrated to inhibit
VSMC proliferation in response to Hcy in another study
Hours
50 µmol/L Hcy
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GRP94
GRP78
PDI
GADD153
Fig. 9. Mesangial cell endoplasmic reticulum stress protein induction
by homocysteine (Hcy). Mesangial cells were exposed to 50 lmol/L Hcy
for the times indicated and protein lysate recovered for immunoblot-
ting with specific antisera. Each lane was loaded with 40 lg protein. A
representative autoradiograph is shown (N = 3).
[66]. VSMC matrix production was also induced by Hcy
in this and other studies [25, 66]. VEC proliferation is, by
contrast, inhibited by Hcy [25, 29]. Clearly, the VSMC,
phenotypically similar to the mesangial cell, displays sim-
ilar responses to injurious stress, proliferation and matrix
production. Recently, though, it has been demonstrated
that Hcy induces type I collagen production in mesangial
cells [24], indicating that Hcy may not just be an epiphe-
nomenon of CRF affecting the systemic vasculature, but
may also contribute to the progression of the underlying
renal disease itself. A recent in vivo study of diet-induced
hyperhomocysteinemia in Dahl salt-sensitive rats also
supports this construct [23].
The mechanisms by which Hcy contributes to the de-
velopment and progression of vascular disease remain
obscure, but several theories have emerged. Studies have
concentrated on oxidative stress induced by peroxide
and free radical generation, hypomethylation, and en-
doplasmic reticulum stress [67]. The differential effects
on VSMC have been attributed to the fact that Hcy is ef-
ficiently converted to s-adenosylhomocysteine (SAH) in
VEC, an inhibitor of methyltransferase, but not in VSMC.
Hypomethylated p21ras was observed [29] and this was
subsequently associated with diminished Erk activity in
VEC, lending credence to this hypothesis [32]. This effect
is not seen in VSMC and, indeed, activation of Erk has
been demonstrated by Hcy in VSMC [31]. It is critical to
note that many studies of the effect of Hcy on vascular
cells used extremely high levels of Hcy (1 mmol/L), lev-
els not attained even in the presence of genetic defects in
Hcy handling.
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Differential display studies suggested a third possible
mechanism for detrimental effects of Hcy, endoplasmic
reticulum stress. Exposure of VEC to Hcy led to up-
regulation of an array of mRNA transcripts primarily in-
volved in the response of the endoplasmic reticulum to
protein misfolding [53], an effect that has variably been
attributed to oxidative [53] or reductive [15] stresses. This
observation, also termed the unfolded protein response
has been confirmed in vivo by our group, who observed in-
duction of endoplasmic reticulum stress proteins and the
unfolded protein response in VSMC and hepatocytes in
a hyperhomocysteinemic mouse model [68]. It was noted
over 10 years ago that Hcy could inhibit the biosynthe-
sis of proteins normally secreted by some cells, and that
this was due to endoplasmic reticulum retention of the
proteins and their ultimate degradation [69]. Induction
of Grp78 and other chaperones accompany the unfolded
protein response, and protect cells from apoptotic death
in response to endoplasmic reticulum stress stimuli. Al-
though we and others have observed endoplasmic retic-
ulum stress in response to Hcy, the mechanism by which
this occurs has remained elusive [68, 69].
Thus, we explored whether Hcy-induced Erk activa-
tion occurred in mesangial cells, and the mechanism(s)
thereof. We observed dose-dependent Erk activation in
mesangial cells, maximally at the physiologically relevant
concentration of 50 lmol/L. Hcy-induced oxidative stress
did not appear to play a role in the induction of Erk, as
the antioxidants catalase and n-acetylcysteine were with-
out effect. AP-1 nuclear protein binding was also un-
affected by antioxidants. These results differ from the
oxidative stress mechanism whereby Hcy induced col-
lagen I production by mesangial cells [24], suggesting
that multiple signaling pathways might potentially be
activated by Hcy in mesangial cells. We did note, how-
ever, that chelation of intracellular calcium with BAPTA-
AM efficiently abrogated Hcy-induced Erk signaling
and markedly decreased AP-1 nuclear protein bind-
ing. In support of this construct, we also observed that
50 lmol/L Hcy induced a prompt increase in intracellu-
lar calcium in mesangial cells. The data presented here,
therefore, indicate that Hcy elicits mesangial cell prolifer-
ation via Erk signaling, and that calcium is indispensable
for this process. Subsequently, we sought to determine
whether mesangial cell proliferation would be observed
in the presence of Hcy, and if this was Erk-dependent,
as has been proposed in VSMC [31]. We observed that
50 lmol/L Hcy, a plasma concentration commonly ob-
served in the setting of ESRD, increased mesangial cell
expression of PCNA at 24 hours. This increase could be
abrogated by PD98059, an inhibitor of Erk, suggesting
that the effect of Hcy of mesangial cell proliferation was
signaled through Erk. We also wished to determine if
Hcy induced endoplasmic reticulum stress in mesangial
cells, given recent observations of the importance of this
effect by ourselves [68] and others [54]. There is ample
data to suggest that Hcy up-regulates several genes as-
sociated with the accumulation of misfolded proteins in
endoplasic reticulum [15, 43, 53], and we observe herein
the same effect in mesangial cells, although at physio-
logically relevant concentrations for the first time in cell
culture. Furthermore, Erk inhibition also prevented the
up-regulation of Grp78 mRNA, indicating that the Hcy-
induced endoplasmic reticulum stress occurred through
Erk activation.
These data support the hypothesis that mesangial cells
respond to Hcy in a similar fashion as VSMC [25, 26, 31],
by proliferation and the induction of endoplasmic reticu-
lum stress. Since mesangial cells have also been recently
shown to increase their production of matrix in response
to Hcy, in vitro evidence now exists to suggest that Hcy
may play a role in the progression of glomerular disease
in the same way that it plays a role in the progression of
vascular disease. As our studies are the first to show these
effects in cultured cells at Hcy levels routinely observed
in vivo, attention should be given to the potential role for
Hcy in the progression of chronic glomerular disease.
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